Evidence map›Paper›PMID 42522240›Full record

ArticleJMIR research protocols2026

Technology Platform (Peer PLUS) Supporting the Work of Peer Recovery Coaches and the Communication Needs of Individuals in Recovery From Substance Use Disorder: Protocol for an R21 Development and Usability Trial.

Amanda Coupe, Jessica Pater, Rachel Pfafman, Victor P Cornet, Elisabeth Andrews, Mindy Flanagan, Dana Albright, Abhinay Balasani, Christopher Becker, Brian Parise and 2 more

Abstract read
In one paragraph

Article in JMIR research protocols, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Amanda CoupeParkview Mirro Center for Research and Innovation, 10622 Parkview Plaza Drive, Fort Wayne, IN, 46845, United States, 1 260-266-5586.ORCID 0000-0003-3825-5968
Jessica PaterParkview Mirro Center for Research and Innovation, 10622 Parkview Plaza Drive, Fort Wayne, IN, 46845, United States, 1 260-266-5586.ORCID 0000-0001-5115-8439
Rachel PfafmanParkview Mirro Center for Research and Innovation, 10622 Parkview Plaza Drive, Fort Wayne, IN, 46845, United States, 1 260-266-5586.ORCID 0000-0002-7741-1241
Victor P CornetParkview Mirro Center for Research and Innovation, 10622 Parkview Plaza Drive, Fort Wayne, IN, 46845, United States, 1 260-266-5586.ORCID 0000-0003-3965-9454
Elisabeth AndrewsParkview Behavioral Health Institute, Parkview Health, Fort Wayne, IN, United States.ORCID 0009-0004-1295-3025
Mindy FlanaganParkview Mirro Center for Research and Innovation, 10622 Parkview Plaza Drive, Fort Wayne, IN, 46845, United States, 1 260-266-5586.ORCID 0000-0002-7146-5628
Dana AlbrightParkview Mirro Center for Research and Innovation, 10622 Parkview Plaza Drive, Fort Wayne, IN, 46845, United States, 1 260-266-5586.ORCID 0000-0002-6394-6763
Abhinay BalasaniParkview Mirro Center for Research and Innovation, 10622 Parkview Plaza Drive, Fort Wayne, IN, 46845, United States, 1 260-266-5586.ORCID 0009-0006-6436-9431
Christopher BeckerParkview Mirro Center for Research and Innovation, 10622 Parkview Plaza Drive, Fort Wayne, IN, 46845, United States, 1 260-266-5586.ORCID 0009-0000-6244-5695
Brian PariseParkview Mirro Center for Research and Innovation, 10622 Parkview Plaza Drive, Fort Wayne, IN, 46845, United States, 1 260-266-5586.ORCID 0009-0001-0903-8406
Erik HessEmergency Medicine, Vanderbilt University Medical Center, Nashville, TN, United States.ORCID 0000-0002-6499-9592
Tammy ToscosParkview Mirro Center for Research and Innovation, 10622 Parkview Plaza Drive, Fort Wayne, IN, 46845, United States, 1 260-266-5586.ORCID 0000-0002-9679-5359

Funding

AHRQ HHS R21 HS028880
6 · The paper itself

Abstract

Background: Substance use disorder (SUD) represents a significant public health concern in the United States. SUD recovery is complex and individualized, and support provided by peer recovery coaches (PRCs) can improve outcomes. The PRC-client relationship requires bidirectional mediated communication that is often informal but should be trackable, efficient, and aligned with health care privacy and security regulations. Current workflows and available apps do not meet these needs, illustrating the opportunity for client-centered technology tools. We have developed Peer PLUS (People Leveraging Urgent Support; Parkview Health System, Inc), a HIPAA (Health Insurance Portability and Accountability Act)-compliant mobile app and client management system, to address this need; however, the platform has not yet been tested in a clinical setting. Objective: We describe the protocol for the evaluation of our digital health platform to identify its perceived usability, potential sustained use, and potential impact on treatment-related outcomes, as well as to assess its feasibility for a future randomized controlled trial and develop an implementation tool kit to facilitate use by other organizations. Methods: Our evaluation leveraged user-centered design (UCD) and implementation science frameworks (Reach, Effectiveness, Adoption, Implementation, and Maintenance [RE-AIM]). We conducted prelaunch ethnographic observations of 3 PRCs' workflows for an understanding of user needs. During subsequent in-the-wild testing, PRC-client dyads will use the platform for asynchronous communication within their standard support relationship. We will deploy periodic electronic surveys, including the System Usability Scale (SUS) to assess perceived usability during beta testing, and additional validated measures assessing specific treatment-related outcomes (ie, recovery, quality of care, and therapeutic alliance) during pilot testing. App use log data will be leveraged to assess the likelihood of sustained use. After each test, UCD-focused stakeholder engagements will further elucidate opportunities for platform refinement and implementation tool kit development. Feasibility targets include SUS scores of 68 or more, 25% client eligibility and enrollment rate, and 20% increased contacts between PRCs and enrolled vs nonenrolled clients. Results: This project was funded in March 2023. Beta test recruitment began in January 2024, with 3 tests completed by November 2024 (3 PRCs and 7 clients). Pilot recruitment began in August 2025. Pilot testing and analyses will continue in 2026. If feasibility metrics are met, the platform will be tested in a later study phase that will include a randomized controlled trial and a second pilot trial to test implementation at a different organization. Conclusions: Our evaluation assesses whether Peer PLUS is an efficient and usable tool that meets identified communication and documentation needs of clients and PRCs while fostering increased connection, which could suggest the likelihood of sustained use and improved treatment outcomes. This project contributes to the UCD and implementation science fields by demonstrating the importance of merging these frameworks during the design and evaluation of novel digital health solutions.

Indexed as

MentoringMobile ApplicationsPeer GroupSubstance-Related DisordersCommunicationHumansUnited Stateshuman-computer interactionimplementation sciencemobile appmobile computingpeer recovery support specialistuser-centered design

Identifiers

PMID42522240
PMCPMC13415650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.